These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9868652)

  • 21. Apparent lack of cross-reactivity for infusion-related reactions between two forms of lipid-based amphotericin B.
    Buckley MS; Anderson CS; Patel SA; Yerondopoulos MJ; Wicks LM; Martin MT
    Am J Health Syst Pharm; 2013 Jun; 70(12):1047-51. PubMed ID: 23719882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pulmonary aspergillosis in the neutropenic patient. Apropos of 4 cases].
    Ben Othman T; Ben Lakhal B; Medini Manai Z; Ladeb S; M'Sadek F; Meddeb B; Ben Abid H; Bel Hadj Ali Z; Hafsia R; Ben Abdeladhim A; Hafsia A
    Tunis Med; 1996 Nov; 74(11):493-500. PubMed ID: 9506113
    [No Abstract]   [Full Text] [Related]  

  • 23. Changes in the natural history of invasive pulmonary aspergillosis in neutropenic leukemic patients.
    Ruchlemer R; Yinnon AM; Hershko C
    Isr J Med Sci; 1996 Nov; 32(11):1089-92. PubMed ID: 8960078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive aspergillosis in severely neutropenic patients over 18 years: impact of intranasal amphotericin B and HEPA filtration.
    Withington S; Chambers ST; Beard ME; Inder A; Allen JR; Ikram RB; Schousboe MI; Heaton DC; Spearing RI; Hart DN
    J Hosp Infect; 1998 Jan; 38(1):11-8. PubMed ID: 9513064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice.
    Wallace TL; Paetznick V; Cossum PA; Lopez-Berestein G; Rex JH; Anaissie E
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2238-43. PubMed ID: 9333054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis.
    Wiederhold NP; Tam VH; Chi J; Prince RA; Kontoyiannis DP; Lewis RE
    Antimicrob Agents Chemother; 2006 Feb; 50(2):469-73. PubMed ID: 16436698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?
    Pagano L; Valentini CG; Fianchi L; Caira M
    J Chemother; 2011 Feb; 23(1):5-8. PubMed ID: 21482486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voriconazole versus amphotericin B for invasive aspergillosis.
    Karthaus M
    N Engl J Med; 2002 Dec; 347(25):2080-1; author reply 2080-1. PubMed ID: 12494937
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and safety of generic amphotericin B in experimental pulmonary aspergillosis.
    Petraitis V; Petraitiene R; Lin P; Calis K; Kelaher AM; Muray HA; Mya-San C; Mickiene D; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1642-5. PubMed ID: 15793161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quiz page. Invasive pulmonary aspergillosis presenting with a pulmonary nodule, pneumomediastinum, pneumothorax, and pneumopericardium.
    Sengul S; Keven K; Kutlay S; Ergun I; Azap A; Erbay B
    Am J Kidney Dis; 2004 Oct; 44(4):A47, E47-9. PubMed ID: 15384032
    [No Abstract]   [Full Text] [Related]  

  • 31. Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokinetics.
    Groll AH; Gonzalez CE; Giri N; Kligys K; Love W; Peter J; Feuerstein E; Bacher J; Piscitelli SC; Walsh TJ
    J Antimicrob Chemother; 1999 Jan; 43(1):95-103. PubMed ID: 10381106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nosocomial cerebral aspergillosis: a report of 3 cases.
    Darras-Joly C; Veber B; Bedos JP; Gachot B; Regnier B; Wolff M
    Scand J Infect Dis; 1996; 28(3):317-9. PubMed ID: 8863371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
    Myoken Y; Sugata T; Kyo T; Fujihara M; Mikami Y
    J Periodontol; 2002 Jan; 73(1):33-8. PubMed ID: 11846198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposomal amphotericin B can safely be administered in paediatric outpatients with cancer for the primary or secondary prevention of invasive aspergillosis.
    Simon A; Bode U; Maul M; Fleischhack G
    Acta Haematol; 2007; 118(2):68-9. PubMed ID: 17538246
    [No Abstract]   [Full Text] [Related]  

  • 35. Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis.
    White MH; Anaissie EJ; Kusne S; Wingard JR; Hiemenz JW; Cantor A; Gurwith M; Du Mond C; Mamelok RD; Bowden RA
    Clin Infect Dis; 1997 Apr; 24(4):635-42. PubMed ID: 9145737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema.
    Purcell IF; Corris PA
    Thorax; 1995 Dec; 50(12):1321-3. PubMed ID: 8553311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients.
    Mills W; Chopra R; Linch DC; Goldstone AH
    Br J Haematol; 1994 Apr; 86(4):754-60. PubMed ID: 7918068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aerosolized antifungal prophylaxis: the winds of change?
    Perfect JR
    Clin Infect Dis; 2008 May; 46(9):1409-11. PubMed ID: 18419444
    [No Abstract]   [Full Text] [Related]  

  • 39. Focus on fungal infections.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Jul; 3(7):27-32. PubMed ID: 11364470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of newer antifungal therapies in clinical practice: what do the data tell us?
    Perfect JR
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.